Microbiome's effect on white matter in autism.

This review explores how gut bacteria might affect brain development in autism. Children with autism show a pattern where brain connections (white matter) develop differently - first growing too much, then not enough. The study found that having fewer good gut bacteria is linked to more severe autism symptoms. The researchers suggest that gut bacteria might influence brain development through chemicals they produce and by affecting inflammation in the brain.

This review examines the relationship between gut microbiome composition and white matter development in autism spectrum disorder. The authors describe a consistent neuroimaging pattern in ASD showing initial white matter hypermyelination followed by reduced myelination compared to typical development. Core ASD symptoms, including social, communication, motor, and sensory difficulties, correlate significantly with white matter abnormalities measured through diffusion tensor imaging. The review presents evidence for bidirectional relationships between gut microbiome diversity and white matter development, with decreased beneficial bacteria (particularly Bifidobacterium and Lactobacillus) correlating with symptom severity.

Proposed mechanisms include direct effects through short-chain fatty acids regulating oligodendrocyte function and indirect effects through neuroinflammatory pathway modulation.

The consistent pattern of white matter abnormalities in ASD may serve as a neurobiological marker. The correlation between gut microbiome diversity and symptom severity suggests that microbiome-targeted interventions could potentially influence both gut health and brain development. The proposed gut-brain axis mechanisms offer novel therapeutic approaches, though more research is needed to establish causality and develop evidence-based interventions.

As a review article, no original data is presented. The mechanistic evidence linking microbiome to white matter development is described as 'emerging,' indicating limited direct evidence. Sample sizes and methodological details of reviewed studies are not provided, making it difficult to assess the strength of individual findings.

Autism spectrum disorder (ASD) is characterized by deficits in social communication and restricted, repetitive behavioral patterns. Although other physiological presentations in individuals with ASD are heterogeneous, neuroimaging studies have consistently revealed a developmental pattern of initial white matter hypermyelination followed by reduced myelination compared with typically developing peers. Multiple studies have demonstrated that core ASD symptoms, including impairments in social skills, language acquisition, learning capabilities, motor performance, and sensory processing, correlate significantly with white matter dysregulation measured through diffusion tensor imaging (DTI). Longitudinal studies have shown that decreased gut microbiome diversity, particularly reductions in beneficial bacteria such as Bifidobacterium and Lactobacillus, correlates with symptom severity.

Emerging mechanistic evidence suggests bidirectional relationships between microbiome composition and white matter development, both directly through metabolites like short-chain fatty acids (SCFAs) that regulate oligodendrocyte function and subsequent myelination, and indirectly through modulation of neuroinflammatory pathways. By integrating molecular-level gut physiology findings with macro-level brain imaging data, we may identify novel therapeutic approaches targeting the gut-brain axis in ASD management.